Today's Date
A Research Trial of Aralast in New Onset Diabetes
(
RETAIN
)
ITN Protocol #:
ITN041AI
Branded Name:
RETAIN
ClinicalTrials.Gov ID:
NCT01183468Treatment Protocol #:
AAT
Therapeutic Area:
Type 1 Diabetes
Current Status:
Complete
Summary:
Effect of Intravenous Alpha-1 Antitrypsin on Preserving Beta-cell Function in New-onset Type 1 Diabetes Mellitus
Clinical Operations Associate Director
ITN Clinical Trials Physician
NIAID Project Manager
Study Personnel:
